Cadence Pharmaceuticals, Inc. (CADX) Posts Slightly Wide Loss of 28c Share

March 12, 2012 4:04 PM EDT
Cadence Pharmaceuticals, Inc. (NASDAQ: CADX) reported Q4 EPS of ($0.28), $0.01 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $5.9 million versus the consensus estimate of $6.88 million.

For earnings history and earnings-related data on Cadence Pharmaceuticals, Inc. (CADX) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings